Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 26 Breast Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 15 Head and Neck Neoplasms 13 Rectal Neoplasms 11 Colonic Neoplasms 11 Prostatic Neoplasms 8 Pancreatic Neoplasms 7 Mouth Neoplasms 6 Glioblastoma 6 Neuroblastoma 5 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Precancerous Conditions 4 Ovarian Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Liver Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Gliosarcoma 4 Carcinoma, Hepatocellular 4 Adenomatous Polyposis Coli 4 Sarcoma 3

Interventions

Tobacco Use Cessation Devices 5 Surveys and Questionnaires 4 Standard of Care 3 Exercise 3 Ethanol 3 Varenicline 2 Tomography, X-Ray Computed 2 Tobacco Products 2 Smoking Devices 2 Radiotherapy 2 Motivational Interviewing 2 olaparib 1 Yoga 1 Videotape Recording 1 Transcranial Direct Current Stimulation 1 Tablets 1 Restraint, Physical 1 Radon 1 Psychiatric Rehabilitation 1 Preoperative Exercise 1 Practice Guidelines as Topic 1 Phlebotomy 1 Patient Navigation 1 Nutritional Support 1 Nicotine Replacement Therapy 1 Nicotine 1 Mindfulness-Based Stress Reduction 1 Mindfulness 1 Methods 1 Mass Screening 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Smoking × Celecoxib × Clear all

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

M.D. Anderson Cancer Center

Phase 3 Completed

Smoking

Data powered by HemOnc (CC BY 4.0) Colophon ⚡